Back to search
Sickle Cell Trait
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Cell Trait trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Cell Trait trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or w…
It is estimated that over 250,000 babies are born with sickle cell disease (SCD) annually in sub-Saharan Africa, and only 10% - 50% of them survive beyond five…
The purpose of this study is to find the smallest amount of the 131 I-apamistamab needed for preparing patients with severe sickle cell disease (SCD) for a bone…
Background: Some people with the same disorder on a genetic level have more complications than others. Researchers want to look for a link between the PKLR gen…
This study will collect representative blood samples from healthy children and adults and from children and adults who have unique red blood cell features that…
Background: Sickle cell disease (SCD) is a genetic disease that causes the body to produce abnormal ( sickled ) red blood cells. SCD can cause anemia and life-…
Erythrocyte morphology analysis is a key step in the diagnosis flowchart of anemia. It is performed on a peripheral blood smear after May Grümwald Giemsa staini…
Background: Venous thromboembolism (VTE) includes the abnormal clotting of blood in a deep vein of the upper or lower limbs (deep vein thrombosis) that may tra…